The Market Reports

Index

1 Mesalamine Market Overview
1.1 Product Overview and Scope of Mesalamine
1.2 Mesalamine Segment by Type
1.2.1 Global Mesalamine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Purity ≥ 97%
1.2.3 Purity ≥ 98%
1.2.4 Purity ≥ 99%
1.3 Mesalamine Segment by Application
1.3.1 Global Mesalamine Sales Comparison by Application: (2021-2027)
1.3.2 Mesalazine Tablets
1.3.3 Mesalazine Capsules
1.3.4 Others
1.4 Global Mesalamine Market Size Estimates and Forecasts
1.4.1 Global Mesalamine Revenue 2016-2027
1.4.2 Global Mesalamine Sales 2016-2027
1.4.3 Mesalamine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Mesalamine Market Competition by Manufacturers
2.1 Global Mesalamine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Mesalamine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Mesalamine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Mesalamine Manufacturing Sites, Area Served, Product Type
2.5 Mesalamine Market Competitive Situation and Trends
2.5.1 Mesalamine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Mesalamine Players Market Share by Revenue
2.5.3 Global Mesalamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Mesalamine Retrospective Market Scenario by Region
3.1 Global Mesalamine Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Mesalamine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Mesalamine Market Facts & Figures by Country
3.3.1 North America Mesalamine Sales by Country
3.3.2 North America Mesalamine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Mesalamine Market Facts & Figures by Country
3.4.1 Europe Mesalamine Sales by Country
3.4.2 Europe Mesalamine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Mesalamine Market Facts & Figures by Region
3.5.1 Asia Pacific Mesalamine Sales by Region
3.5.2 Asia Pacific Mesalamine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Mesalamine Market Facts & Figures by Country
3.6.1 Latin America Mesalamine Sales by Country
3.6.2 Latin America Mesalamine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Mesalamine Market Facts & Figures by Country
3.7.1 Middle East and Africa Mesalamine Sales by Country
3.7.2 Middle East and Africa Mesalamine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Mesalamine Historic Market Analysis by Type
4.1 Global Mesalamine Sales Market Share by Type (2016-2021)
4.2 Global Mesalamine Revenue Market Share by Type (2016-2021)
4.3 Global Mesalamine Price by Type (2016-2021)

5 Global Mesalamine Historic Market Analysis by Application
5.1 Global Mesalamine Sales Market Share by Application (2016-2021)
5.2 Global Mesalamine Revenue Market Share by Application (2016-2021)
5.3 Global Mesalamine Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Syntese A/S
6.1.1 Syntese A/S Corporation Information
6.1.2 Syntese A/S Description and Business Overview
6.1.3 Syntese A/S Mesalamine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Syntese A/S Mesalamine Product Portfolio
6.1.5 Syntese A/S Recent Developments/Updates
6.2 Divis Laboratories
6.2.1 Divis Laboratories Corporation Information
6.2.2 Divis Laboratories Description and Business Overview
6.2.3 Divis Laboratories Mesalamine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Divis Laboratories Mesalamine Product Portfolio
6.2.5 Divis Laboratories Recent Developments/Updates
6.3 Cambrex Corporation
6.3.1 Cambrex Corporation Corporation Information
6.3.2 Cambrex Corporation Description and Business Overview
6.3.3 Cambrex Corporation Mesalamine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Cambrex Corporation Mesalamine Product Portfolio
6.3.5 Cambrex Corporation Recent Developments/Updates
6.4 Ipca Laboratories
6.4.1 Ipca Laboratories Corporation Information
6.4.2 Ipca Laboratories Description and Business Overview
6.4.3 Ipca Laboratories Mesalamine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Ipca Laboratories Mesalamine Product Portfolio
6.4.5 Ipca Laboratories Recent Developments/Updates
6.5 Hangzhou Brother
6.5.1 Hangzhou Brother Corporation Information
6.5.2 Hangzhou Brother Description and Business Overview
6.5.3 Hangzhou Brother Mesalamine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Hangzhou Brother Mesalamine Product Portfolio
6.5.5 Hangzhou Brother Recent Developments/Updates
6.6 PharmaZell
6.6.1 PharmaZell Corporation Information
6.6.2 PharmaZell Description and Business Overview
6.6.3 PharmaZell Mesalamine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 PharmaZell Mesalamine Product Portfolio
6.6.5 PharmaZell Recent Developments/Updates
6.7 Lianyungang Fengheng Biopharm
6.6.1 Lianyungang Fengheng Biopharm Corporation Information
6.6.2 Lianyungang Fengheng Biopharm Description and Business Overview
6.6.3 Lianyungang Fengheng Biopharm Mesalamine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Lianyungang Fengheng Biopharm Mesalamine Product Portfolio
6.7.5 Lianyungang Fengheng Biopharm Recent Developments/Updates
6.8 Lasa Loboratory
6.8.1 Lasa Loboratory Corporation Information
6.8.2 Lasa Loboratory Description and Business Overview
6.8.3 Lasa Loboratory Mesalamine Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Lasa Loboratory Mesalamine Product Portfolio
6.8.5 Lasa Loboratory Recent Developments/Updates
6.9 Erregierre SpA
6.9.1 Erregierre SpA Corporation Information
6.9.2 Erregierre SpA Description and Business Overview
6.9.3 Erregierre SpA Mesalamine Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Erregierre SpA Mesalamine Product Portfolio
6.9.5 Erregierre SpA Recent Developments/Updates
6.10 Corden Pharma Bergamo
6.10.1 Corden Pharma Bergamo Corporation Information
6.10.2 Corden Pharma Bergamo Description and Business Overview
6.10.3 Corden Pharma Bergamo Mesalamine Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Corden Pharma Bergamo Mesalamine Product Portfolio
6.10.5 Corden Pharma Bergamo Recent Developments/Updates
6.11 CTX Lifescience
6.11.1 CTX Lifescience Corporation Information
6.11.2 CTX Lifescience Mesalamine Description and Business Overview
6.11.3 CTX Lifescience Mesalamine Sales, Revenue and Gross Margin (2016-2021)
6.11.4 CTX Lifescience Mesalamine Product Portfolio
6.11.5 CTX Lifescience Recent Developments/Updates
6.12 Ishita Active Pharma Ingredients
6.12.1 Ishita Active Pharma Ingredients Corporation Information
6.12.2 Ishita Active Pharma Ingredients Mesalamine Description and Business Overview
6.12.3 Ishita Active Pharma Ingredients Mesalamine Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Ishita Active Pharma Ingredients Mesalamine Product Portfolio
6.12.5 Ishita Active Pharma Ingredients Recent Developments/Updates
6.13 YC Biotech (Jiangsu)
6.13.1 YC Biotech (Jiangsu) Corporation Information
6.13.2 YC Biotech (Jiangsu) Mesalamine Description and Business Overview
6.13.3 YC Biotech (Jiangsu) Mesalamine Sales, Revenue and Gross Margin (2016-2021)
6.13.4 YC Biotech (Jiangsu) Mesalamine Product Portfolio
6.13.5 YC Biotech (Jiangsu) Recent Developments/Updates
6.14 Xinxiang Tianfeng Fine Chemical
6.14.1 Xinxiang Tianfeng Fine Chemical Corporation Information
6.14.2 Xinxiang Tianfeng Fine Chemical Mesalamine Description and Business Overview
6.14.3 Xinxiang Tianfeng Fine Chemical Mesalamine Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Xinxiang Tianfeng Fine Chemical Mesalamine Product Portfolio
6.14.5 Xinxiang Tianfeng Fine Chemical Recent Developments/Updates

7 Mesalamine Manufacturing Cost Analysis
7.1 Mesalamine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Mesalamine
7.4 Mesalamine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Mesalamine Distributors List
8.3 Mesalamine Customers

9 Mesalamine Market Dynamics
9.1 Mesalamine Industry Trends
9.2 Mesalamine Growth Drivers
9.3 Mesalamine Market Challenges
9.4 Mesalamine Market Restraints

10 Global Market Forecast
10.1 Mesalamine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Mesalamine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Mesalamine by Type (2022-2027)
10.2 Mesalamine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Mesalamine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Mesalamine by Application (2022-2027)
10.3 Mesalamine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Mesalamine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Mesalamine by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Mesalamine Sales (MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Mesalamine Sales (MT) Comparison by Application (2021-2027)
Table 3. Global Mesalamine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Mesalamine Covered in This Study
Table 5. Global Mesalamine Sales (MT) of Key Manufacturers (2016-2021)
Table 6. Global Mesalamine Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Mesalamine Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Mesalamine Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Mesalamine Average Price (USD/Kg) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Mesalamine Manufacturing Sites and Area Served
Table 11. Manufacturers Mesalamine Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Mesalamine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mesalamine as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Mesalamine Sales by Region (2016-2021) & (MT)
Table 16. Global Mesalamine Sales Market Share by Region (2016-2021)
Table 17. Global Mesalamine Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Mesalamine Sales by Country (2016-2021) & (MT)
Table 19. North America Mesalamine Sales Market Share by Country (2016-2021)
Table 20. North America Mesalamine Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Mesalamine Revenue Market Share by Country (2016-2021)
Table 22. Europe Mesalamine Sales by Country (2016-2021) & (MT)
Table 23. Europe Mesalamine Sales Market Share by Country (2016-2021)
Table 24. Europe Mesalamine Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Mesalamine Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Mesalamine Sales by Region (2016-2021) & (MT)
Table 27. Asia Pacific Mesalamine Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Mesalamine Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Mesalamine Revenue Market Share by Region (2016-2021)
Table 30. Latin America Mesalamine Sales by Country (2016-2021) & (MT)
Table 31. Latin America Mesalamine Sales Market Share by Country (2016-2021)
Table 32. Latin America Mesalamine Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Mesalamine Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Mesalamine Sales by Country (2016-2021) & (MT)
Table 35. Middle East and Africa Mesalamine Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Mesalamine Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Mesalamine Revenue Market Share by Country (2016-2021)
Table 38. Global Mesalamine Sales (MT) by Type (2016-2021)
Table 39. Global Mesalamine Sales Market Share by Type (2016-2021)
Table 40. Global Mesalamine Revenue (Million US$) by Type (2016-2021)
Table 41. Global Mesalamine Revenue Share by Type (2016-2021)
Table 42. Global Mesalamine Price (USD/Kg) by Type (2016-2021)
Table 43. Global Mesalamine Sales (MT) by Application (2016-2021)
Table 44. Global Mesalamine Sales Market Share by Application (2016-2021)
Table 45. Global Mesalamine Revenue (Million US$) by Application (2016-2021)
Table 46. Global Mesalamine Revenue Share by Application (2016-2021)
Table 47. Global Mesalamine Price (USD/Kg) by Application (2016-2021)
Table 48. Syntese A/S Corporation Information
Table 49. Syntese A/S Description and Business Overview
Table 50. Syntese A/S Mesalamine Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 51. Syntese A/S Mesalamine Product
Table 52. Syntese A/S Recent Developments/Updates
Table 53. Divis Laboratories Corporation Information
Table 54. Divis Laboratories Description and Business Overview
Table 55. Divis Laboratories Mesalamine Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 56. Divis Laboratories Mesalamine Product
Table 57. Divis Laboratories Recent Developments/Updates
Table 58. Cambrex Corporation Corporation Information
Table 59. Cambrex Corporation Description and Business Overview
Table 60. Cambrex Corporation Mesalamine Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 61. Cambrex Corporation Mesalamine Product
Table 62. Cambrex Corporation Recent Developments/Updates
Table 63. Ipca Laboratories Corporation Information
Table 64. Ipca Laboratories Description and Business Overview
Table 65. Ipca Laboratories Mesalamine Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 66. Ipca Laboratories Mesalamine Product
Table 67. Ipca Laboratories Recent Developments/Updates
Table 68. Hangzhou Brother Corporation Information
Table 69. Hangzhou Brother Description and Business Overview
Table 70. Hangzhou Brother Mesalamine Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 71. Hangzhou Brother Mesalamine Product
Table 72. Hangzhou Brother Recent Developments/Updates
Table 73. PharmaZell Corporation Information
Table 74. PharmaZell Description and Business Overview
Table 75. PharmaZell Mesalamine Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 76. PharmaZell Mesalamine Product
Table 77. PharmaZell Recent Developments/Updates
Table 78. Lianyungang Fengheng Biopharm Corporation Information
Table 79. Lianyungang Fengheng Biopharm Description and Business Overview
Table 80. Lianyungang Fengheng Biopharm Mesalamine Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 81. Lianyungang Fengheng Biopharm Mesalamine Product
Table 82. Lianyungang Fengheng Biopharm Recent Developments/Updates
Table 83. Lasa Loboratory Corporation Information
Table 84. Lasa Loboratory Description and Business Overview
Table 85. Lasa Loboratory Mesalamine Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 86. Lasa Loboratory Mesalamine Product
Table 87. Lasa Loboratory Recent Developments/Updates
Table 88. Erregierre SpA Corporation Information
Table 89. Erregierre SpA Description and Business Overview
Table 90. Erregierre SpA Mesalamine Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 91. Erregierre SpA Mesalamine Product
Table 92. Erregierre SpA Recent Developments/Updates
Table 93. Corden Pharma Bergamo Corporation Information
Table 94. Corden Pharma Bergamo Description and Business Overview
Table 95. Corden Pharma Bergamo Mesalamine Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 96. Corden Pharma Bergamo Mesalamine Product
Table 97. Corden Pharma Bergamo Recent Developments/Updates
Table 98. CTX Lifescience Corporation Information
Table 99. CTX Lifescience Description and Business Overview
Table 100. CTX Lifescience Mesalamine Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 101. CTX Lifescience Mesalamine Product
Table 102. CTX Lifescience Recent Developments/Updates
Table 103. Ishita Active Pharma Ingredients Corporation Information
Table 104. Ishita Active Pharma Ingredients Description and Business Overview
Table 105. Ishita Active Pharma Ingredients Mesalamine Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 106. Ishita Active Pharma Ingredients Mesalamine Product
Table 107. Ishita Active Pharma Ingredients Recent Developments/Updates
Table 108. YC Biotech (Jiangsu) Corporation Information
Table 109. YC Biotech (Jiangsu) Description and Business Overview
Table 110. YC Biotech (Jiangsu) Mesalamine Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 111. YC Biotech (Jiangsu) Mesalamine Product
Table 112. YC Biotech (Jiangsu) Recent Developments/Updates
Table 113. Xinxiang Tianfeng Fine Chemical Corporation Information
Table 114. Xinxiang Tianfeng Fine Chemical Description and Business Overview
Table 115. Xinxiang Tianfeng Fine Chemical Mesalamine Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 116. Xinxiang Tianfeng Fine Chemical Mesalamine Product
Table 117. Xinxiang Tianfeng Fine Chemical Recent Developments/Updates
Table 118. Production Base and Market Concentration Rate of Raw Material
Table 119. Key Suppliers of Raw Materials
Table 120. Mesalamine Distributors List
Table 121. Mesalamine Customers List
Table 122. Mesalamine Market Trends
Table 123. Mesalamine Growth Drivers
Table 124. Mesalamine Market Challenges
Table 125. Mesalamine Market Restraints
Table 126. Global Mesalamine Sales Forecast by Type (2022-2027) & (MT)
Table 127. Global Mesalamine Sales Market Share Forecast by Type (2022-2027)
Table 128. Global Mesalamine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 129. Global Mesalamine Revenue Market Share Forecast by Type (2022-2027)
Table 130. Global Mesalamine Sales Forecast by Application (2022-2027) & (MT)
Table 131. Global Mesalamine Sales Market Share Forecast by Application (2022-2027)
Table 132. Global Mesalamine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 133. Global Mesalamine Revenue Market Share Forecast by Application (2022-2027)
Table 134. Global Mesalamine Sales Forecast by Region (2022-2027) & (MT)
Table 135. Global Mesalamine Sales Market Share Forecast by Region (2022-2027)
Table 136. Global Mesalamine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 137. Global Mesalamine Revenue Market Share Forecast by Region (2022-2027)
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Mesalamine
Figure 2. Global Mesalamine Market Share by Type in 2020 & 2027
Figure 3. Purity ≥ 97% Product Picture
Figure 4. Purity ≥ 98% Product Picture
Figure 5. Purity ≥ 99% Product Picture
Figure 6. Global Mesalamine Market Share by Application in 2020 & 2027
Figure 7. Mesalazine Tablets
Figure 8. Mesalazine Capsules
Figure 9. Others
Figure 10. Global Mesalamine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Mesalamine Market Size 2016-2027 (US$ Million)
Figure 12. Global Mesalamine Sales 2016-2027 (MT)
Figure 13. Global Mesalamine Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Mesalamine Sales Share by Manufacturers in 2020
Figure 15. Global Mesalamine Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Mesalamine Players: Market Share by Revenue in 2020
Figure 17. Mesalamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Mesalamine Sales Market Share by Region (2016-2021)
Figure 19. Global Mesalamine Sales Market Share by Region in 2020
Figure 20. Global Mesalamine Revenue Market Share by Region (2016-2021)
Figure 21. Global Mesalamine Revenue Market Share by Region in 2020
Figure 22. U.S. Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. UAE Mesalamine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Mesalamine by Type (2016-2021)
Figure 47. Sales Market Share of Mesalamine by Application (2016-2021)
Figure 48. Sales Market Share of Mesalamine by Application in 2020
Figure 49. Revenue Share of Mesalamine by Application (2016-2021)
Figure 50. Revenue Share of Mesalamine by Application in 2020
Figure 51. Manufacturing Cost Structure of Mesalamine
Figure 52. Manufacturing Process Analysis of Mesalamine
Figure 53. Mesalamine Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed